@prefix : <http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#> .
@prefix mp: <http://purl.org/mp/> .
@prefix oa: <http://www.w3.org/ns/oa#> .
@prefix opv: <http://inab.certh.gr/OpenPVSignal> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xml: <http://www.w3.org/XML/1998/namespace> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix openpvsignal: <http://purl.org/OpenPVSignal/OpenPVSignal.owl> .
@base <http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl> .

<http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl> rdf:type owl:Ontology ;
                                                                                                owl:imports <http://purl.org/OpenPVSignal/OpenPVSignal.owl> ;
                                                                                                rdfs:isDefinedBy "https://apps.who.int/iris/handle/10665/311036/"^^xsd:anyURI ;
                                                                                                rdfs:label "Methotrexate - Incorrect drug administration rate"^^rdfs:Literal ;
                                                                                                owl:versionInfo "draft-v0.95-20210520"@en .

#################################################################
#    Object Properties
#################################################################

###  http://purl.org/OpenPVSignal/OpenPVSignal.owl#Free_text_reporting_element
<http://purl.org/OpenPVSignal/OpenPVSignal.owl#Free_text_reporting_element> rdf:type owl:ObjectProperty .


###  http://purl.org/mp/publishedBy
mp:publishedBy rdf:type owl:ObjectProperty .


###  http://purl.org/mp/references
mp:references rdf:type owl:ObjectProperty .


###  http://purl.org/mp/supportedByData
mp:supportedByData rdf:type owl:ObjectProperty .


#################################################################
#    Classes
#################################################################

###  http://www.w3.org/ns/prov#Organization
<http://www.w3.org/ns/prov#Organization> rdf:type owl:Class .


#################################################################
#    Individuals
#################################################################

###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#AcuteLymphocyticLeukaemia
:AcuteLymphocyticLeukaemia rdf:type owl:NamedIndividual ,
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "C91.0" ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10000846 ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Acute lymphocytic leukaemia" ;
                           rdfs:label "Acute lymphocytic leukaemia" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#B-cellLymphoma
:B-cellLymphoma rdf:type owl:NamedIndividual ,
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "C85.1" ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10003899 ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "	B-cell lymphoma	" ;
                rdfs:label "B-cell lymphoma" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#Breast_carcinoma
:Breast_carcinoma rdf:type owl:NamedIndividual ,
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "D05" ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10006204 ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Breast carcinoma" ;
                  rdfs:label "Breast carcinoma" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#Bulgaria
:Bulgaria rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallReportsInVigibase2009-2018 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 3 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_country> "http://dbpedia.org/resource/Bulgaria" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
          rdfs:label "Reports from Bulgaria" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#Cancer
:Cancer rdf:type owl:NamedIndividual ,
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "C80" ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10028997 ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Neoplasm malignant" ;
        rdfs:label "Cancer" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#Denmark
:Denmark rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallReportsInVigibase2009-2018 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 1 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_country> "http://dbpedia.org/resource/Denmark" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
         rdfs:label "Reports from Denmark" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#Dose_of_Methotrexate
:Dose_of_Methotrexate rdf:type owl:NamedIndividual ,
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :Psoriasis ,
                                                                                                  :RheumatoidArthritis ;
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :Methotrexate ;
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "In the treatment of rheumatoid arthritis and psoriasis, methotrexate is given as a weekly dose. This dose can be divided into three doses to be taken within 24 hours, at 12-hour intervals (applicable for the tablet formulation)." ;
                      rdfs:label "Dose of Methotrexate for psoriasis and rheumatoid arthritis" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#Dose_of_Methotrexate_for_cancer
:Dose_of_Methotrexate_for_cancer rdf:type owl:NamedIndividual ,
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :Cancer ;
                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :Methotrexate ;
                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """In cancer treatment, single doses of methotrexate are given on not more than 
five consecutive days, followed by a rest period of at least two weeks between treatments.""" ;
                                 rdfs:label "Dose of Methotrexate for cancer" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#Germany
:Germany rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallReportsInVigibase2009-2018 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 1 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_country> "http://dbpedia.org/resource/Germany" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
         rdfs:label "Reports from Germany" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#IncorrectDrugAdministrationRate
:IncorrectDrugAdministrationRate rdf:type owl:NamedIndividual ,
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Medication_Errors> ;
                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "T887" ;
                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10064306 ;
                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Incorrect drug administration rate" ;
                                 rdfs:label "Incorrect drug administration rate" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#Incorrect_drug_dose_administration_of_Methotrexate
:Incorrect_drug_dose_administration_of_Methotrexate rdf:type owl:NamedIndividual ,
                                                             <http://purl.obolibrary.org/obo/OAE_0000056> ;
                                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :IncorrectDrugAdministrationRate ;
                                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :Methotrexate ;
                                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "In the cases where oral methotrexate was prescribed, the patients had taken it daily instead of weekly. In one case, a prescription error was reported. However, in most cases it appears that the patient did not understand that methotrexate was to be taken weekly and not daily" ;
                                                    rdfs:label "Dose of Methotrexate" ,
                                                               "Incorrect drug dose administration of Methotrexate" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#Intravenous_administration_methortrexate
:Intravenous_administration_methortrexate rdf:type owl:NamedIndividual ,
                                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :Methotrexate ;
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "injected (intraveneous)" ;
                                          rdfs:label "Intravenous administration methortrexate" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#Marian_Atalla
:Marian_Atalla rdf:type owl:NamedIndividual ,
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Author> ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_affiliation> "Uppsala Monitoring Centre" ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_first_name> "Marian" ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_last_name> "Attalla" ;
               rdfs:label "Marian Attalla" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#Mechanism_of_Methotrexate
:Mechanism_of_Methotrexate rdf:type owl:NamedIndividual ,
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Mechanism> ;
                           mp:references :Ref._1 ,
                                         :Ref._2 ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Methotrexate is a folic acid antagonist used in the treatment of rheumatoid arthritis and severe psoriasis when the patient has been unresponsive to other, conventional therapies.1,2 It is also used to induce regression in neoplastic conditions such as acute leukaemia, non-Hodgkin's lymphoma, soft-tissue and osteogenic sarcomas, and solid tumours such as breast, lung, head and neck, bladder, cervix, ovaries, and testicles carcinoma." ;
                           rdfs:label "Mechanism of Methotrexate" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#Methotrexate
:Methotrexate rdf:type owl:NamedIndividual ,
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :AcuteLymphocyticLeukaemia ,
                                                                                          :B-cellLymphoma ,
                                                                                          :Breast_carcinoma ,
                                                                                          :Psoriasis ,
                                                                                          :RheumatoidArthritis ,
                                                                                          :Sarcoma_osteogenic ,
                                                                                          :Soft_tissue_sarcoma ,
                                                                                          :asthma ,
                                                                                          :bladderCarcinoma ,
                                                                                          :bullousPemphigoid ,
                                                                                          :cerebralLymphoma ,
                                                                                          :cervixCarcinoma ,
                                                                                          :headCarcinoma ,
                                                                                          :lungCarcinoma ,
                                                                                          :neckCarcinoma ,
                                                                                          :ovaryCarcinoma ,
                                                                                          :testiclesCarcinoma ,
                                                                                          <http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#non-Hogkin's_lymphoma> ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_mechanism> :Incorrect_drug_dose_administration_of_Methotrexate ,
                                                                            :Mechanism_of_Methotrexate ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "L04AX03" ;
              rdfs:label "Methotrexate" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#Oral_administration_methortrexate
:Oral_administration_methortrexate rdf:type owl:NamedIndividual ,
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :Methotrexate ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                   rdfs:label "Oral administration methortrexate" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#OverallReportsInVigibase2009-2018
:OverallReportsInVigibase2009-2018 rdf:type owl:NamedIndividual ,
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :Methotrexate ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_medication_error> :IncorrectDrugAdministrationRate ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 24 ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count_of_men> 15 ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count_of_women> 9 ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                   rdfs:label "Overall reports in Vigibase 2009-2018" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#PV_signal_for_Methotrexate_and_Incorrect_drug_administration_rate_UMC_WHO_report
:PV_signal_for_Methotrexate_and_Incorrect_drug_administration_rate_UMC_WHO_report rdf:type owl:NamedIndividual ,
                                                                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Signal> ;
                                                                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Free_text_reporting_element> :Reports_in_Vigibase ,
                                                                                                                                                              :conclusion ,
                                                                                                                                                              :introduction ;
                                                                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :ReportsWithFatalOutcome ;
                                                                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_supported_by_statistical_entity> :Bulgaria ,
                                                                                                                                                                     :Denmark ,
                                                                                                                                                                     :Germany ,
                                                                                                                                                                     :OverallReportsInVigibase2009-2018 ,
                                                                                                                                                                     :ReportsFromFrance ,
                                                                                                                                                                     :ReportsInWhichAgeIsProvided ,
                                                                                                                                                                     :ReportsWithFatalOutcome ,
                                                                                                                                                                     :ReportsWithIVAdministration ,
                                                                                                                                                                     :ReportsWithNoRecovery ,
                                                                                                                                                                     :ReportsWithOralAdministration ,
                                                                                                                                                                     :ReportsWithPositiveOutcome ,
                                                                                                                                                                     :Spain ,
                                                                                                                                                                     :Switzerland ,
                                                                                                                                                                     :UK ,
                                                                                                                                                                     :USA ,
                                                                                                                                                                     :Unknown ,
                                                                                                                                                                     :reportsWithAsthmaAsIndication ,
                                                                                                                                                                     :reportsWithBullousPemphigoidAsIndication ,
                                                                                                                                                                     :reportsWithGastritis ,
                                                                                                                                                                     :reportsWithPancytopenia ,
                                                                                                                                                                     :reportsWithPharyngitis ,
                                                                                                                                                                     :reportsWithPsoriasisAsIndication ,
                                                                                                                                                                     :reportsWithRheumatoidArthritisAsIndication ,
                                                                                                                                                                     :reportsWithThrombocytopenia ,
                                                                                                                                                                     :reportsWithVariousCancersAsIndication ,
                                                                                                                                                                     :reprortsWithMouthUlceration ;
                                                                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :IncorrectDrugAdministrationRate ,
                                                                                                                                                           :gastritis ,
                                                                                                                                                           :mouthUlceration ,
                                                                                                                                                           :pancytopenia ,
                                                                                                                                                           :pharyngitis ,
                                                                                                                                                           :thrombocytopenia ;
                                                                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :Methotrexate ;
                                                                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_medication_error> :IncorrectDrugAdministrationRate ;
                                                                                  mp:supportedByData :Warning_for_Methotrexate_use ;
                                                                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#initially_identified_on> "01/01/2019" ;
                                                                                  rdfs:label "PV signal for Methotrexate and Incorrect drug administration rate UMC WHO report" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#Psoriasis
:Psoriasis rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "L40" ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10037153 ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Psoriasis" ;
           rdfs:label "Psoriasis" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#Ref._1
:Ref._1 rdf:type owl:NamedIndividual ,
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Bibliographic_reference> ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Summary of Product Characteristics for Methotrexate. Available from: https://www.medicines.org.uk/emc/product/13 76. Accessed: January 2018." ;
        rdfs:label "Ref. 1" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#Ref._2
:Ref._2 rdf:type owl:NamedIndividual ,
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Bibliographic_reference> ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "US Food and Drug Administration: Product label for methotrexate. Available from: https://dailymed. nlm.nih.gov/dailymed/drugInfo.cfm?setid=8f- 1260de-b60c-4f0e-8af6- 0e957b0a281b&audience=-consumer. Accessed: January 2018." ;
        rdfs:label "Ref. 2" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#Ref._3
:Ref._3 rdf:type owl:NamedIndividual ,
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Bibliographic_reference> ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Product Information Leaflet for Methotrexate. Available from: https://www.medicines.org.uk/emc/ product/1376/pil. Accessed: January 2018." ;
        rdfs:label "Ref. 3" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#ReportsFromFrance
:ReportsFromFrance rdf:type owl:NamedIndividual ,
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallReportsInVigibase2009-2018 ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 13 ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_country> "http://dbpedia.org/resource/France" ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                   rdfs:label "Reports from France" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#ReportsInWhichAgeIsProvided
:ReportsInWhichAgeIsProvided rdf:type owl:NamedIndividual ,
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallReportsInVigibase2009-2018 ;
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 21 ;
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_max_age> 92 ;
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_median_age> 63 ;
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_min_age> 3 ;
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                             rdfs:label "Reports in which age is provided" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#ReportsWithFatalOutcome
:ReportsWithFatalOutcome rdf:type owl:NamedIndividual ,
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallReportsInVigibase2009-2018 ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 2 ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "death" ;
                         rdfs:label "Reports with fatal outcome" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#ReportsWithIVAdministration
:ReportsWithIVAdministration rdf:type owl:NamedIndividual ,
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Intravenous_administration_methortrexate ;
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallReportsInVigibase2009-2018 ;
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 5 ;
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                             rdfs:label "Reports with IV administration" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#ReportsWithNoRecovery
:ReportsWithNoRecovery rdf:type owl:NamedIndividual ,
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallReportsInVigibase2009-2018 ;
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 1 ;
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "no recovery" ;
                       rdfs:label "Reports with no recovery" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#ReportsWithOralAdministration
:ReportsWithOralAdministration rdf:type owl:NamedIndividual ,
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Oral_administration_methortrexate ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallReportsInVigibase2009-2018 ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "In the cases where oral methotrexate was prescribed, the patients had taken it daily instead of weekly" ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 19 ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                               rdfs:label "Reports with oral administration" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#ReportsWithPositiveOutcome
:ReportsWithPositiveOutcome rdf:type owl:NamedIndividual ,
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallReportsInVigibase2009-2018 ;
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 15 ;
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "recovery with no further information" ;
                            rdfs:label "Reports with positive outcome" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#Reports_in_Vigibase
:Reports_in_Vigibase rdf:type owl:NamedIndividual ,
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Free_text_reporting_element> ;
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "In VigiBase, there are 24 cases reporting incorrect drug administration rate for methotrexate between 2009 and January 2018.  Thirteen cases are from France, three from Bulgaria, three from USA, and one each from Denmark, Germany, Spain, Switzerland and UK.  The patient age ranged from 3 to 92 years, with a median age of 63 years, based on the 21 reports where age was provided . Men accounted for 15 and women for 9 reports . The indications for treatment were reported as psoriasis in three cases, rheumatoid arthritis in three cases, various cancers in three cases (acute lymphocytic leukaemia, B cell lymphoma, cerebral lymphoma), bullous pemphigoid in one case and asthma in another case.  In the remaining 13 cases, the indication was unspecified. Methotrexate was administered intravenously in five cases and orally in 19 cases. In the cases where oral methotrexate was prescribed, the patients had taken it daily instead of weekly. In one case, a prescription error was reported. However, in most cases it appears that the patient did not understand that methotrexate was to be taken weekly and not daily.  In addition to errors in administration, other reactions were reported. The five most reported reactions included mouth ulceration (4), thrombocytopenia (4), gastritis (4), pancytopenia (3) and pharyngitis (3).  The outcome was recovered in 15 cases, not recovered in one case and unknown in another case. In the remaining two cases, the patient died." ;
                     rdfs:label "Reports in Vigibase" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#RheumatoidArthritis
:RheumatoidArthritis rdf:type owl:NamedIndividual ,
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "M06" ;
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10039073 ;
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Rheumatoid arthritis" ;
                     rdfs:label "Rheumatoid arthritis" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#Sarcoma_osteogenic
:Sarcoma_osteogenic rdf:type owl:NamedIndividual ,
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "C41.9" ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10039496 ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Sarcoma osteogenic" ;
                    rdfs:label "Sarcoma osteogenic" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#Soft_tissue_sarcoma
:Soft_tissue_sarcoma rdf:type owl:NamedIndividual ,
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "C49.9" ;
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10075333 ;
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Soft tissue sarcoma" ;
                     rdfs:label "Soft tissue sarcoma" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#Spain
:Spain rdf:type owl:NamedIndividual ,
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallReportsInVigibase2009-2018 ;
       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 1 ;
       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_country> "http://dbpedia.org/resource/Spain" ;
       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
       rdfs:label "Reports from Spain" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#Switzerland
:Switzerland rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallReportsInVigibase2009-2018 ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 1 ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_country> "http://dbpedia.org/resource/Switzerland" ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
             rdfs:label "Reports from Switzerland" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#UK
:UK rdf:type owl:NamedIndividual ,
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallReportsInVigibase2009-2018 ;
    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 1 ;
    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_country> "http://dbpedia.org/resource/United_Kingdom" ;
    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
    rdfs:label "Reports from UK" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#USA
:USA rdf:type owl:NamedIndividual ,
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallReportsInVigibase2009-2018 ;
     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 3 ;
     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_country> "http://dbpedia.org/resource/United_States" ;
     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
     rdfs:label "Reports from USA" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#Unknown
:Unknown rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallReportsInVigibase2009-2018 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 1 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "unknown" ;
         rdfs:label "Reports with unknown outcome" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#Uppsale_Monitoring_Centre
:Uppsale_Monitoring_Centre rdf:type owl:NamedIndividual ,
                                    <http://www.w3.org/ns/prov#Organization> ;
                           rdfs:label "Upsalla Monitoring Centre" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#Warning_for_Methotrexate_use
:Warning_for_Methotrexate_use rdf:type owl:NamedIndividual ,
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Literature_information> ,
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Structured_Product_Labels_information> ,
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Warning_Information> ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :Methotrexate ;
                              mp:references :Ref._1 ,
                                            :Ref._3 ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Both the Summary of Product Characteristics (SmPC) and the Patient Information Leaflet (PIL) state that methotrexate is to be taken weekly.1,3" ;
                              rdfs:label "SmPC and PIL for Methotrexate use" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#asthma
:asthma rdf:type owl:NamedIndividual ,
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "J45" ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10003553 ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Asthma" ;
        rdfs:label "asthma" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#bladderCarcinoma
:bladderCarcinoma rdf:type owl:NamedIndividual ,
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "C67.9" ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10005014 ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Bladder carcinoma" ;
                  rdfs:label "bladder carcinoma" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#bullousPemphigoid
:bullousPemphigoid rdf:type owl:NamedIndividual ,
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "L12.0" ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10006567 ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Bullous pemphigoid" ;
                   rdfs:label "bullous pemphigoid" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#cerebralLymphoma
:cerebralLymphoma rdf:type owl:NamedIndividual ,
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "C83.80" ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10051811 ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Cerebral lymphoma" ;
                  rdfs:label "cerebral lymphoma" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#cervixCarcinoma
:cervixCarcinoma rdf:type owl:NamedIndividual ,
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "C539" ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10008342 ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Cervix carcinoma" ;
                 rdfs:label "cervix carcinoma" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#conclusion
:conclusion rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Conclusion> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Based on the reports in VigiBase, it appears that clearer instructions both in the SPC and by the prescriber are necessary, and that health care professionals should verify that the patient has understood how the medication needs to be taken." ;
            rdfs:label "conclusion" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#gastritis
:gastritis rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "K29" ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10017853 ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Gastritis" ;
           rdfs:label "gastritis" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#headCarcinoma
:headCarcinoma rdf:type owl:NamedIndividual ,
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "C76.0" ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10067821 ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> """Head and neck cancer
""" ;
               rdfs:label "head carcinoma" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#introduction
:introduction rdf:type owl:NamedIndividual ,
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Introduction> ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Methotrexate is a folic acid antagonist used in the treatment of rheumatoid arthritis and severe psoriasis when the patient has been unresponsive to other, conventional therapies.1,2 It is also used to induce regression in neoplastic conditions such as acute leukaemia, non-Hodgkin's lymphoma, soft-tissue and osteogenic sarcomas, and solid tumours such as breast, lung, head and neck, bladder, cervix, ovaries, and testicles carcinoma . In the treatment of rheumatoid arthritis and psoriasis, methotrexate is given as a weekly dose . This dose can be divided into three doses to be taken within 24 hours, at 12-hour intervals (applicable for the tablet formulation). In cancer treatment, single doses of methotrexate are given on not more than five consecutive days, followed by a rest period of at least two weeks between treatments" ;
              rdfs:label "introduction" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#lungCarcinoma
:lungCarcinoma rdf:type owl:NamedIndividual ,
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "C34" ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10058467 ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Lung neoplasm malignant" ;
               rdfs:label "lung carcinoma" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#mouthUlceration
:mouthUlceration rdf:type owl:NamedIndividual ,
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "K123" ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10028034 ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Mouth ulceration" ;
                 rdfs:label "mouth ulceration" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#neckCarcinoma
:neckCarcinoma rdf:type owl:NamedIndividual ,
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "C76.0" ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10067821 ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> """Head and neck cancer
""" ;
               rdfs:label "neck carcinoma" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#ovaryCarcinoma
:ovaryCarcinoma rdf:type owl:NamedIndividual ,
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "C56" ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10033131 ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Ovarian carcinoma	" ;
                rdfs:label "ovary carcinoma" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#pancytopenia
:pancytopenia rdf:type owl:NamedIndividual ,
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "D61.81" ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10033661 ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Pancytopenia" ;
              rdfs:label "pancytopenia" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#pharyngitis
:pharyngitis rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "J02.9" ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10034835 ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Pharyngitis" ;
             rdfs:label "pharyngitis" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#reportsWithAsthmaAsIndication
:reportsWithAsthmaAsIndication rdf:type owl:NamedIndividual ,
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :asthma ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallReportsInVigibase2009-2018 ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 1 ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                               rdfs:label "reports with asthma as indication" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#reportsWithBullousPemphigoidAsIndication
:reportsWithBullousPemphigoidAsIndication rdf:type owl:NamedIndividual ,
                                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :bullousPemphigoid ;
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallReportsInVigibase2009-2018 ;
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 1 ;
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                          rdfs:label "reports with bullous pemphigoid as indication" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#reportsWithGastritis
:reportsWithGastritis rdf:type owl:NamedIndividual ,
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallReportsInVigibase2009-2018 ;
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :gastritis ;
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 4 ;
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                      rdfs:label "reports with gastritis" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#reportsWithPancytopenia
:reportsWithPancytopenia rdf:type owl:NamedIndividual ,
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallReportsInVigibase2009-2018 ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :pancytopenia ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 3 ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                         rdfs:label "reports with pancytopenia" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#reportsWithPharyngitis
:reportsWithPharyngitis rdf:type owl:NamedIndividual ,
                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallReportsInVigibase2009-2018 ;
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :pharyngitis ;
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 3 ;
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                        rdfs:label "reports with pharyngitis" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#reportsWithPsoriasisAsIndication
:reportsWithPsoriasisAsIndication rdf:type owl:NamedIndividual ,
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :Psoriasis ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallReportsInVigibase2009-2018 ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 3 ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                  rdfs:label "reports with psoriasis as indication" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#reportsWithRheumatoidArthritisAsIndication
:reportsWithRheumatoidArthritisAsIndication rdf:type owl:NamedIndividual ,
                                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :RheumatoidArthritis ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallReportsInVigibase2009-2018 ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 3 ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                            rdfs:label "reports with rheumatoid arthritis as indication" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#reportsWithThrombocytopenia
:reportsWithThrombocytopenia rdf:type owl:NamedIndividual ,
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallReportsInVigibase2009-2018 ;
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :thrombocytopenia ;
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 4 ;
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                             rdfs:label "reports with thrombocytopenia" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#reportsWithVariousCancersAsIndication
:reportsWithVariousCancersAsIndication rdf:type owl:NamedIndividual ,
                                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :AcuteLymphocyticLeukaemia ,
                                                                                                                   :B-cellLymphoma ,
                                                                                                                   :cerebralLymphoma ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallReportsInVigibase2009-2018 ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 3 ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                       rdfs:label "reports with various cancers as indication" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#reprortsWithMouthUlceration
:reprortsWithMouthUlceration rdf:type owl:NamedIndividual ,
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallReportsInVigibase2009-2018 ;
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :mouthUlceration ;
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 4 ;
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                             rdfs:label "reports with mouth ulceration" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#testiclesCarcinoma
:testiclesCarcinoma rdf:type owl:NamedIndividual ,
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "C62" ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10057644 ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Testis cancer" ;
                    rdfs:label "testicles carcinoma" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#thrombocytopenia
:thrombocytopenia rdf:type owl:NamedIndividual ,
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "D69.6" ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10043554 ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Thrombocytopenia" ;
                  rdfs:label "thrombocytopenia" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#Methotrexate__Incorrect_drug_administration_rate_UMC_WHO_report
<http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#Methotrexate__Incorrect_drug_administration_rate_UMC_WHO_report> rdf:type owl:NamedIndividual ,
                                                                                                                                                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Pharmacovigilance_Signal_Report> ;
                                                                                                                                                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_author> :Marian_Atalla ;
                                                                                                                                                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_signal> :PV_signal_for_Methotrexate_and_Incorrect_drug_administration_rate_UMC_WHO_report ;
                                                                                                                                                                mp:publishedBy :Uppsale_Monitoring_Centre ;
                                                                                                                                                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_creation_date> "01/01/2019"^^xsd:date ;
                                                                                                                                                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_overall_conclusion> "causal association" ;
                                                                                                                                                                rdfs:label "Methotrexate  Incorrect drug administration rate UMC WHO report" .


###  http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#non-Hogkin's_lymphoma
<http://purl.org/OpenPVSignal/Signals/2019_1_methotrexate_incorrectDrugAdministrationRate.owl#non-Hogkin's_lymphoma> rdf:type owl:NamedIndividual ,
                                                                                                                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
                                                                                                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "C85.90" ;
                                                                                                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10029547 ;
                                                                                                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Non-Hodgkin's lymphoma" ;
                                                                                                                     rdfs:label "non-Hogkin's lymphoma" .


###  Generated by the OWL API (version 4.5.9.2019-02-01T07:24:44Z) https://github.com/owlcs/owlapi
